Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? – study protocol for a randomized controlled trial [NCT00120978]

BACKGROUND: Systemic inflammation is associated with various complications in chronic obstructive pulmonary disease including weight loss, cachexia, osteoporosis, cancer and cardiovascular diseases. Inhaled corticosteroids attenuate airway inflammation, reduce exacerbations, and improve mortality in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sin, Don D, Man, SF Paul, Marciniuk, Darcy D, Ford, Gordon, FitzGerald, Mark, Wong, Eric, York, Ernest, Mainra, Rajesh R, Ramesh, Warren, Melenka, Lyle S, Wilde, Eric, Cowie, Robert L, Williams, Dave, Rousseau, Roxanne
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373664/
https://www.ncbi.nlm.nih.gov/pubmed/16460562
http://dx.doi.org/10.1186/1471-2466-6-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373664/
https://www.ncbi.nlm.nih.gov/pubmed/16460562
http://dx.doi.org/10.1186/1471-2466-6-3

Ejemplares similares